Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05053126 · ClinicalTrials.gov registry record · Phase 4
Study Evaluating Abuse Potential of Lyrica® in Healthy Non-Drug Dependent Recreational Opioid Users
A Phase 4 study, sponsored by Viatris Specialty.
- Completed
- Registry status
- Phase 4
- Development phase
- 60
- Enrollment target
NCT05053126: Completed Phase 4 study, sponsored by Viatris Specialty.
NCT05053126 is a Phase 4 study that has completed, run by Viatris Specialty. The registered enrollment target is 60 participants, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (88% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05053126, a Phase 4 study, has completed, sponsored by Viatris Specialty.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 60 participants
- Enrollment target
Study Summary
This is a Phase 4 clinical study in healthy non-drug dependent recreational opioid users to assess the abuse potential of Lyrica when taken alone or in combination with oxycodone.
Primary Outcome
Drug liking assesses how much a participant likes or dislikes a drug effect at the time the question ("at this moment, my liking this drug is") is being asked. It is scored using a 100 mm visual analogue scale (VAS), where 0 mm = "Strong Disliking", 50 mm = "Neither Like nor Dislike", and 100 mm = "Strong Liking"
Interventions
- DRUG Pregabalin 300mg
- DRUG pregabalin 450 mg
- DRUG Pregabalin 300 mg with oxycodone 20 mg
- DRUG pregabalin 450 mg with oxycodone 20 mg
- DRUG oxycodone 20 mg
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 60 participants |
| Start Date | 2021-07-27 |
| Est. Completion | 2022-04-01 |
| Phase | Phase 4 |
What the finished NCT05053126 record still lists
NCT05053126 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 60 participants, a relatively small participant target, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (88% lower).
The record links to 0 conditions, and to 5 interventions - of which Pregabalin 300mg is the first listed.
NCT05053126 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT05053126 about?
NCT05053126 is a clinical study titled "Study Evaluating Abuse Potential of Lyrica® in Healthy Non-Drug Dependent Recreational Opioid Users". This is a Phase 4 clinical study in healthy non-drug dependent recreational opioid users to assess the abuse potential of Lyrica when taken alone or in combination with oxycodone.
What is the current status of trial NCT05053126?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 60 participants. The study started on 2021-07-27. Estimated completion is 2022-04-01.
What interventions are being tested in trial NCT05053126?
The interventions under investigation include: Pregabalin 300mg (DRUG), pregabalin 450 mg (DRUG), Pregabalin 300 mg with oxycodone 20 mg (DRUG), pregabalin 450 mg with oxycodone 20 mg (DRUG), oxycodone 20 mg (DRUG).
Who is sponsoring clinical trial NCT05053126?
This trial is sponsored by Viatris Specialty, which has 5 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT05053126's enrollment target sits among peer trials
60 1125th of 2000 higher than 799 of 2,000 other Phase 4 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 4 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00576069 · 60 participants
Mechanism(s)of Airflow Limitation in Moderate-severe Persistent Asthma
- NCT01297400 · 60 participants · Phase 2
Phase 2 Pilot Study of the Safety and Efficacy of Topical MW-III in Thermal Burns
- NCT01734122 · 60 participants
Stereotactic Radiosurgery for Essential Tremor and Parkinsonian Tremor
- NCT01804634 · 60 participants · Phase 2
Reduced Intensity Haploidentical BMT for High Risk Solid Tumors
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI